Pulmonx (LUNG) Operating Leases (2019 - 2025)

Pulmonx (LUNG) has 7 years of Operating Leases data on file, last reported at $18.1 million in Q4 2025.

• Quarterly Operating Leases fell 2.46% year-over-year to $18.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $18.1 million (down 2.46% YoY) and the FY2025 annual result came in at $18.1 million, down 2.46% from the prior year.
• Operating Leases fell to $18.1 million in Q4 2025 per LUNG's latest filing, from $19.4 million in the prior quarter.
• Across five years, Operating Leases topped out at $19.4 million in Q3 2025 and bottomed at $1.1 million in Q4 2023.
• The 5-year median for Operating Leases is $7.5 million (2021), against an average of $10.0 million.
• The widest annual swing landed in 2023, when Operating Leases tumbled 71.27%; it then soared 1574.05% in 2024.
• Tracing LUNG's Operating Leases over 5 years: stood at $6.8 million in 2021, then tumbled by 43.76% to $3.8 million in 2022, then plunged by 71.27% to $1.1 million in 2023, then soared by 1574.05% to $18.5 million in 2024, then slipped by 2.46% to $18.1 million in 2025.
• Per Business Quant, the three latest LUNG Operating Leases figures stand at $18.1 million (Q4 2025), $19.4 million (Q3 2025), and $18.6 million (Q2 2025).

Peer Comparison